Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study
- PMID: 27660378
- PMCID: PMC5837634
- DOI: 10.1093/eurheartj/ehw411
Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study
Abstract
Aims: Evidence supporting yearly influenza vaccination in patients with chronic heart failure (HF) is limited, consequently leading to inconsistent guideline recommendations. We aimed to investigate the impact of influenza vaccination on the risk of hospitalization in HF patients.
Methods and results: We used linked primary and secondary health records in England between 1990 and 2013. Using a self-controlled case series design with conditional Poisson regression, we estimated the incidence rate ratio (IRR, 95% CI) of the number of hospitalizations in a year following vaccination with an adjacent vaccination-free year in the same individuals. We found the uptake of vaccination to be varied and generally low (49% in 2013). Among 59,202 HF patients, influenza vaccination was associated with a lower risk of hospitalization due to cardiovascular disease (0.73 [0.71, 0.76]), with more modest effects for hospitalization due to respiratory infections (0.83 [0.77, 0.90]), and all-cause hospitalizations (0.96 [0.95, 0.98]). The relative effects were somewhat greater in younger patients but with no material difference between men and women. In validation analyses, effects were not significant for consecutive years without vaccination (0.96 [0.92, 1.00]) or hospitalization due to cancer (1.02 [0.84, 1.22]).
Conclusion: In HF patients, influenza vaccination is associated with reduced risk of hospitalizations, especially for cardiovascular disease. Improved efforts for wider uptake of vaccination among HF patients are needed.
Keywords: Heart failure; Hospitalization; Influenza vaccination.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For Permissions, please email: journals.permissions@oup.com.
Figures
Comment in
-
Influenza vaccination: a one-shot deal to reduce cardiovascular events.Eur Heart J. 2017 Feb 1;38(5):334-337. doi: 10.1093/eurheartj/ehw560. Eur Heart J. 2017. PMID: 27856498 No abstract available.
Similar articles
-
Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure.JACC Heart Fail. 2018 Oct;6(10):844-855. doi: 10.1016/j.jchf.2018.04.012. Epub 2018 Aug 8. JACC Heart Fail. 2018. PMID: 30098960
-
Influenza Vaccination and Outcome in Heart Failure.Am J Cardiol. 2020 Aug 1;128:134-139. doi: 10.1016/j.amjcard.2020.05.019. Epub 2020 May 18. Am J Cardiol. 2020. PMID: 32650907
-
Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.CMAJ. 2016 Oct 4;188(14):E342-E351. doi: 10.1503/cmaj.151059. Epub 2016 Jul 25. CMAJ. 2016. PMID: 27455981 Free PMC article.
-
Influenza infection and heart failure-vaccination may change heart failure prognosis?Heart Fail Rev. 2017 May;22(3):329-336. doi: 10.1007/s10741-017-9614-7. Heart Fail Rev. 2017. PMID: 28508293 Free PMC article. Review.
-
Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.JACC Heart Fail. 2017 Mar;5(3):194-203. doi: 10.1016/j.jchf.2016.12.007. Epub 2017 Feb 1. JACC Heart Fail. 2017. PMID: 28161238 Free PMC article. Review.
Cited by
-
Association between Mycoplasma pneumoniae infection, high‑density lipoprotein metabolism and cardiovascular health (Review).Biomed Rep. 2024 Jan 18;20(3):39. doi: 10.3892/br.2024.1729. eCollection 2024 Mar. Biomed Rep. 2024. PMID: 38357242 Free PMC article. Review.
-
Immunizing hearts: exploring the vaccination frontier in heart failure management.Ann Med Surg (Lond). 2023 Nov 7;86(1):300-307. doi: 10.1097/MS9.0000000000001486. eCollection 2024 Jan. Ann Med Surg (Lond). 2023. PMID: 38222749 Free PMC article. Review.
-
Pleiotropic Effects of Influenza Vaccination.Vaccines (Basel). 2023 Aug 25;11(9):1419. doi: 10.3390/vaccines11091419. Vaccines (Basel). 2023. PMID: 37766096 Free PMC article. Review.
-
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2023 Sep 5;6(9):e2331284. doi: 10.1001/jamanetworkopen.2023.31284. JAMA Netw Open. 2023. PMID: 37707817 Free PMC article. Clinical Trial.
-
Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?Front Public Health. 2023 Jun 7;11:1203550. doi: 10.3389/fpubh.2023.1203550. eCollection 2023. Front Public Health. 2023. PMID: 37351094 Free PMC article.
References
-
- Upshur RE, Knight K, Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. Am J Epidemiol 1999;149:85–92. - PubMed
-
- Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, McMurray JJ,, Solomon SD, PARADIGM-HF Investigators. Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial. JACC Heart Fail 2015;4:152–158. - PubMed
-
- Udell JA, Farkouh ME, Solomon SD, Vardeny O. Does influenza vaccination influence cardiovascular complications? Expert Rev Cardiovasc Ther 2015;13:593–596. - PubMed
-
- Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients. JAMA 2013;310:1711.. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
